Kharbanda S, Pandey P, Ren R, Mayer B, Zon L, Kufe D
Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 1995 Dec 22;270(51):30278-81. doi: 10.1074/jbc.270.51.30278.
Previous work has shown that treatment of cells with the antimetabolite 1-beta-D-arabinofuranosylcytosine (ara-C) is associated with induction of the c-jun gene. The present studies demonstrate that ara-C activates the c-Abl non-receptor tyrosine kinase. We also demonstrate that activity of the stress-activated protein kinase (SAP kinase/JNK) is increased in ara-C-treated cells. Using cells deficient in c-Abl (Abl-/-) and after introduction of the c-abl gene, we show that ara-C-induced c-Abl activity is necessary for the stimulation of SAP kinase. Other studies using cells transfected with a SEK1 dominant negative demonstrate that ara-C-induced SAP kinase activity is SEK1-dependent. Furthermore, we show that overexpression of truncated c-Abl results in activation of the SEK1/SAP kinase cascade.
先前的研究表明,用抗代谢物1-β-D-阿拉伯呋喃糖基胞嘧啶(ara-C)处理细胞与c-jun基因的诱导有关。目前的研究表明,ara-C可激活c-Abl非受体酪氨酸激酶。我们还证明,在ara-C处理的细胞中,应激激活蛋白激酶(SAP激酶/JNK)的活性增加。利用缺乏c-Abl的细胞(Abl-/-)并在导入c-abl基因后,我们表明ara-C诱导的c-Abl活性是刺激SAP激酶所必需的。使用转染了SEK1显性阴性的细胞进行的其他研究表明,ara-C诱导的SAP激酶活性是SEK1依赖性的。此外,我们表明截短的c-Abl的过表达导致SEK1/SAP激酶级联的激活。